| Breast cancer is the second most common type of | | | | Competition in the global mammography equipment |
| cancer after lung cancer worldwide and the fifth | | | | market |
| most common cause of cancer death. It is found | | | | North American mammography market and market |
| more in women as compared to men. Worldwide | | | | share of main players |
| more than one million new cases of breast cancer | | | | Role of MRIs and ultrasound |
| are found every year. New breast cancer cases are | | | | 3.2 Blood-based Diagnostic Test |
| mostly found in North America. | | | | Blood based breast cancer diagnostic tests |
| Breast cancer is usually found in women over the age | | | | Potential market in India and the UK |
| of 40 years. Breast cancer cases have risen about | | | | 3.3 Biopsy Market |
| 30% in the past 25 years in western countries like | | | | Global breast biopsy market size and growth |
| the US and Europe. Breast cancer market is | | | | Market share of main players in the global breast |
| comprised of two segments - diagnostic and therapy. | | | | biopsy market |
| The key drivers of breast cancer market are aging | | | | Various breast biopsy methods |
| population, obesity and family history among others. | | | | 4. Breast Cancer Treatment Market |
| The stages of breast cancer are of critical | | | | 4.1 Therapy Market |
| importance and decide the treatment method and | | | | Use of therapies at different stages of breast cancer |
| the extent to which it can be cured. Mammography is | | | | 4.1.1 Radiotherapy Market |
| believed to find 85% to 90% of breast cancers in | | | | Market share of main players in radiation therapy |
| women over 50, and can discover a lesion one to | | | | market |
| four years before a lump can be felt. In case of | | | | 4.1.2 Chemotherapy and Taxane Drugs Market |
| patients with dense breast tissue, breast implants or | | | | Global Taxane drug market size |
| patients who are breastfeeding, mammography | | | | Abraxane drug market size and forecast |
| cannot produce clear images and therefore, in such | | | | Abraxane market share in the US |
| cases, ultrasound or MRI is recommended. Biopsy is | | | | 5. Market Movements |
| used for the diagnosis of breast cancer once a lesion | | | | 5.1 Growth drivers |
| is detected in screening. For treatment of breast | | | | 5.1.1 Aging Population |
| cancer, surgery is used first and then drugs or | | | | 5.1.2 Family history of breast cancer |
| radiation therapy or both are used. | | | | 5.1.3 Hormonal factors |
| The major players of breast cancer market are | | | | 5.1.4 High breast tissue density |
| strengthening their networks through international | | | | 5.1.5 Obesity |
| alliances, agreements, strategic acquisitions, exploring | | | | 5.2 Key Issues |
| new markets and R&D initiatives that will help in | | | | 5.2.1 Mammogram radiation raises breast cancer risk in |
| more effective diagnosis and treatment of breast | | | | women |
| cancer. | | | | 5.2.2 Lack of health insurers |
| This report provides an overview of the breast | | | | 5.3 Breast Care Market Trends |
| cancer, its types and stages, and incidence rates. The | | | | 5.3.1 Advances in Imaging Technology for Screening |
| markets for diagnosis and treatment of breast | | | | 5.3.2 Advances in Imaging Technology for Biopsy |
| cancer have been analyzed. Markets for diagnosis and | | | | 5.3.3 Paradigm Shift to Less Invasive Procedures |
| treatment like, mammography, biopsy, | | | | 5.3.4 Emergence of Integrated Breast Centers |
| chemotherapy, radiotherapy and drugs have also | | | | 6. Company Profiles |
| been discussed. The report also analyzes the drivers, | | | | 6.1 Hologic Inc. |
| issues and trends in the breast care market. The | | | | Business Overview |
| major players in the market are profiled along with | | | | Business Strategies |
| their key business strategies. | | | | Expanding through acquisitions |
| Table of Contents : | | | | Introducing 3D digital technology |
| 1. Breast Cancer Types and Stages | | | | 6.2 SenoRx, Inc |
| Types of breast cancer | | | | Business Overview |
| Stages of breast cancer | | | | Business Strategies |
| Survival rates at different stages of breast cancer | | | | Provide Differentiated, Tailored Solutions in the Breast |
| 2. Breast Cancer Market Overview | | | | Biopsy Market |
| Deaths in males/females by age group and region | | | | Leveraging R&D Competencies |
| New breast cancer cases in different regions of the | | | | Pursue Strategic Acquisitions and Partnerships |
| world | | | | 6.3 Johnson and Johnson |
| US breast cancer incidence/death rates by race/color | | | | Business Overview |
| Causes of cancer | | | | Business Strategies |
| 2.1 Breast Cancer Screening, Diagnosis and Treatment | | | | Acquisitions to strengthen business |
| Screening, diagnosis and treatment processes | | | | Creating franchises in Pharmaceutical business |
| Use of drugs and therapies in treatment of breast | | | | 6.4 Siemens AG |
| cancer | | | | Business Overview |
| 3. Screening/Diagnostics Market | | | | Business Strategies |
| 3.1 Mammography | | | | Company reorganization |
| Global mammography market and its segments | | | | Improving Healthcare worldwide |
| Share of different regional markets in mammography | | | | 7. |
| Drivers of mammography market | | | | |